Preclinical Evaluation of A Potent 2nd Generation Small-Molecule Hsp90 Inhibitor STA-9090 In Hematological Cell Lines

被引：0

|

作者：

Ying, Weiwen ^{[1
]}

Proia, David ^{[1
]}

He, Suqin ^{[1
]}

Sang, Jim ^{[1
]}

Foley, Kevin ^{[1
]}

Du, Zhenjian ^{[1
]}

Blackman, Ronald K. ^{[1
]}

Wada, Yumiko ^{[1
]}

Sun, Lijun ^{[1
]}

Koya, Keizo ^{[1
]}

机构：

[1] Synta Pharmaceut, Lexington, MA USA

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1194 / 1194

页数：1

相关论文

共 33 条

[31] The Novel 2nd Generation Small Molecule MEK Inhibitor, AZD-6244, Induces Cell Death in Lymphoma Cells Lines, Primary Cells, and in a Human Lymphoma Xenograft Model
Bhalla, Savita
Gartenhaus, Ron
Dai, Bojie
Prachand, Sheila
Mukherjee, Arindam
Elstrom, Rebecca L.
Gordon, Leo I.
Evens, Andrew M.
BLOOD, 2009, 114 (22) : 120 - 120
[32] The 2nd Generation Proteasome Inhibitor, MLN2238: Potent Induction of Cell Death in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL) Cell Lines and in Two Human Lymphoma Xenograft Models
Dashnamoorthy, Ravi
Kandela, Irawati
Bhalla, Savita
Galloway, Jasmine
Zaretsky, Irina
Mazar, Andrew
Evens, Andrew M.
BLOOD, 2012, 120 (21)
[33] Evaluation of TW-37, a pan Bcl-2 proteins small-molecule inhibitor, against spectrum of human B-cell lines and patient-derived samples
Mohammad, Ramzi M.
Sun, Yuan
Wang, Shaomeng
Aboukameel, Amro
Al-Katib, Ayad M.
BLOOD, 2007, 110 (11) : 202B - 202B

← 1 2 3 4 →